HDHODH-IN-11
HDHODH-IN-11 is a potent human dihydroorotate dehydrogenase (hDHODH) inhibitor with an IC50 value of 7.2 nM. hDHODH-IN-11 has low cytotoxicity. hDHODH-IN-11 can be used in research of acute myeloid leukemia (AML) [1].
Product Specifications
CAS Number
[2396653-34-0]
UNSPSC
12352005
Target
Dihydroorotate Dehydrogenase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hdhodh-in-11.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=C2C=CC=CN2N=C1O)NC3=CC(C)=C(OC4=CC=CC=C4)C=C3C(C)C
Molecular Formula
C24H23N3O3
Molecular Weight
401.46
References & Citations
[1]Sainas S, et, al. Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Aryloxyaryl Moiety. J Med Chem. 2022 Oct 13;65 (19) :12701-12724.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Human Monoclonal Poly-Ubiquitin Antibody (Genentech patent anti-Polyubiquitin) [Janelia Fluor 635]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
NBP3-27986JF635 0.1 mL
Human Monoclonal Poly-Ubiquitin Antibody (Genentech patent anti-Polyubiquitin) [Janelia Fluor 635]
Ask
View Details 
368231 100 µg
LTBR (Tumor necrosis factor receptor superfamily member 3, Lymphotoxin-beta receptor, Tumor necrosis factor C receptor, Tumor necrosis factor receptor 2-related protein, Tumor necrosis factor receptor type III, D12S370, LT-BETA-R, TNF-R-III, TNFCR, TNFR-RP, TNFR2-RP, TNFRSF3)
Ask
View Details